Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 102.1
(-1.22%)
CNY 102.1
(-1.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 303.97 Million CNY | 30.63% |
| 2022 | 232.69 Million CNY | 35.8% |
| 2021 | 171.34 Million CNY | 77.45% |
| 2020 | 96.55 Million CNY | 44.8% |
| 2019 | 66.68 Million CNY | 228.32% |
| 2018 | 20.31 Million CNY | 612.11% |
| 2017 | -3.96 Million CNY | -183.99% |
| 2016 | -1.39 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 102.9 Million CNY | 97.86% |
| 2024 Q2 | 105.13 Million CNY | 2.17% |
| 2023 Q1 | 78.39 Million CNY | 132.64% |
| 2023 FY | 303.97 Million CNY | 30.63% |
| 2023 Q4 | 52 Million CNY | -41.43% |
| 2023 Q3 | 88.78 Million CNY | 4.72% |
| 2023 Q2 | 84.78 Million CNY | 8.15% |
| 2022 FY | 232.69 Million CNY | 35.8% |
| 2022 Q4 | 33.7 Million CNY | -55.56% |
| 2022 Q3 | 75.83 Million CNY | 17.62% |
| 2022 Q2 | 64.47 Million CNY | 9.85% |
| 2022 Q1 | 58.69 Million CNY | 89.13% |
| 2021 Q1 | 36 Million CNY | 29.07% |
| 2021 Q3 | 48.86 Million CNY | -11.86% |
| 2021 Q2 | 55.44 Million CNY | 53.97% |
| 2021 Q4 | 31.03 Million CNY | -36.49% |
| 2021 FY | 171.34 Million CNY | 77.45% |
| 2020 Q3 | 31.12 Million CNY | -8.8% |
| 2020 Q1 | 3.41 Million CNY | -80.64% |
| 2020 FY | 96.55 Million CNY | 44.8% |
| 2020 Q4 | 27.89 Million CNY | -10.36% |
| 2020 Q2 | 34.12 Million CNY | 899.1% |
| 2019 Q4 | 17.64 Million CNY | 42.89% |
| 2019 FY | 66.68 Million CNY | 228.32% |
| 2019 Q3 | 12.34 Million CNY | -36.79% |
| 2019 Q2 | 19.53 Million CNY | 13.82% |
| 2019 Q1 | 17.16 Million CNY | 364.08% |
| 2018 Q4 | 3.69 Million CNY | 0.0% |
| 2018 FY | 20.31 Million CNY | 612.11% |
| 2017 FY | -3.96 Million CNY | -183.99% |
| 2016 FY | -1.39 Million CNY | 0.0% |